Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang, Hengyou Weng, Jianjun Chen
Cancer Cell (2020) Vol. 37, Iss. 3, pp. 270-288
Open Access | Times Cited: 889

Showing 1-25 of 889 citing articles:

The role of m6A modification in the biological functions and diseases
Xiulin Jiang, Baiyang Liu, Zhi Nie, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1244
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su, Lei Dong, Yangchan Li, et al.
Cancer Cell (2020) Vol. 38, Iss. 1, pp. 79-96.e11
Open Access | Times Cited: 550
Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng, Wanxu Huang, Yangqiu Li, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 390
A comprehensive review of m6A/m6Am RNA methyltransferase structures
Stephanie Oerum, Vincent Meynier, Marjorie Catala, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 13, pp. 7239-7255
Open Access | Times Cited: 320
RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Cancer Stem Cell Self-Renewal in Acute Myeloid Leukemia
Chao Shen, Yue Sheng, Allen Zhu, et al.
Cell stem cell (2020) Vol. 27, Iss. 1, pp. 64-80.e9
Open Access | Times Cited: 289
R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis
Ying Qing, Lei Dong, Lei Gao, et al.
Molecular Cell (2021) Vol. 81, Iss. 5, pp. 922-939.e9
Open Access | Times Cited: 226
Mechanism of RNA modification N6-methyladenosine in human cancer
Zijian Zhou, Jiancheng Lv, Hao Yu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 221
ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1
Yunhao Chen, Yanchun Zhao, Junru Chen, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 215
Role of m6A RNA methylation in cardiovascular disease (Review)
Yuhan Qin, Linqing Li, Erfei Luo, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 6, pp. 1958-1972
Open Access | Times Cited: 215
METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis
Rui Su, Lei Dong, Yangchan Li, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 2, pp. 205-216
Open Access | Times Cited: 211
The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth
Lihui Dong, Chuanyuan Chen, Yawei Zhang, et al.
Cancer Cell (2021) Vol. 39, Iss. 7, pp. 945-957.e10
Open Access | Times Cited: 185
Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming
Funmilayo O. Adeshakin, Adeleye O. Adeshakin, Lukman O. Afolabi, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 182
N6-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation
Yuanming Cheng, Wei Xie, Brian F. Pickering, et al.
Cancer Cell (2021) Vol. 39, Iss. 7, pp. 958-972.e8
Open Access | Times Cited: 175
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
Wei Huang, Tian-Qi Chen, Ke Fang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 172
RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 170
LNC942 promoting METTL14-mediated m6A methylation in breast cancer cell proliferation and progression
Tong Sun, Zhikun Wu, Xiufang Wang, et al.
Oncogene (2020) Vol. 39, Iss. 31, pp. 5358-5372
Closed Access | Times Cited: 162
Insights into N6-methyladenosine and programmed cell death in cancer
Li Liu, Hui Li, Dingyu Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160
Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation
Ryan L. Kan, Jianjun Chen, Tamer Sallam
Trends in Genetics (2021) Vol. 38, Iss. 2, pp. 182-193
Open Access | Times Cited: 159
New insights into the interplay between long non‐coding RNAs and RNA‐binding proteins in cancer
Ziting Yao, Yuan‐Han Yang, Miaomiao Sun, et al.
Cancer Communications (2022) Vol. 42, Iss. 2, pp. 117-140
Open Access | Times Cited: 156
The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia
Hengyou Weng, Feng Huang, Zhaojin Yu, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1566-1582.e10
Open Access | Times Cited: 156
Post-translational modification of RNA m6A demethylase ALKBH5 regulates ROS-induced DNA damage response
Fang Yu, Jiangbo Wei, Xiaolong Cui, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 10, pp. 5779-5797
Open Access | Times Cited: 144
Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR
Hailing Liu, Tian Lan, Hui Li, et al.
Theranostics (2020) Vol. 11, Iss. 3, pp. 1396-1411
Open Access | Times Cited: 141
m6A transferase METTL3‐induced lncRNA ABHD11‐AS1 promotes the Warburg effect of non‐small‐cell lung cancer
Lei Xue, Jun Li, Yi-Hui Lin, et al.
Journal of Cellular Physiology (2020) Vol. 236, Iss. 4, pp. 2649-2658
Closed Access | Times Cited: 140
Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 139
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100720-100720
Closed Access | Times Cited: 136
Page 1 - Next Page

Scroll to top